ARF改变PAF1复合体的完整性,在p53损失时选择性地抑制瘤转录程序
Jinli Wang1, Nikole L Fendler2, Ashutosh Shukla1
1Department of Microbiology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Molecular cell
|November 12, 2024
概括
替代阅读框架 (ARF) 瘤抑制剂通过分解PAF1复合体 (PAF1c) 和调节RUNX1.1,抑制瘤转录. 失去ARF通过GDF/BMP信号传递促进细胞生长,提供治疗点.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 转录条例 转录条例 转录条例
背景情况:
- 聚合酶相关因子1 (PAF1) 复合体 (PAF1c) 对于RNA聚合酶II (RNA Pol II) 转录延长至关重要.
- 在细胞命运过渡过程中PAF1c活动的调节尚未得到充分理解.
- 替代阅读框架 (ARF) 瘤抑制剂在防止不受控制的细胞生长方面发挥着作用.
研究的目的:
- 研究ARF在细胞命运过渡期间对PAF1c活动的调节机制.
- 阐明ARF如何抑制瘤性转录程序.
- 确定针对ARF介导瘤抑制的潜在治疗策略.
主要方法:
- 研究了ARF与PAF1子单元的相互作用及其对PAF1c分解的影响.
- 分析了ARF针对RUNX1进行选择性基因转录调整的向.
- 利用p53损失的小鼠细胞模型来研究ARF的功能.
- 评估了GDF/BMP信号传递和RUNX1扰动对细胞增殖的影响.
主要成果:
- ARF通过与PAF1亚单元结合来促进PAF1c的分解,从而减少RNA Pol II相互作用和转录.
- 通过准RUNX1.1,ARF可以选择性地调节基因转录.
- 失去ARF会导致RUNX1-和PAF1c-依赖的GDF/BMP配体的激活,促进异常细胞生长.
- 药物抑制GDF/BMP信号传递和RUNX1的遗传干扰减弱了p53和ARF缺乏细胞中的细胞增殖.
结论:
- 通过双重机制,ARF通过抑制PAF1c依赖的瘤转录来起到关键的瘤抑制作用.
- ARF对PAF1c和RUNX1的调节控制了细胞生长途径,特别是GDF/BMP-Smad1/5轴.
- 准GDF/BMP信号传输或RUNX1为具有双重p53和ARF损失的癌症提供了潜在的治疗途径.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


